SILO PHARMA, INC. Increase (Decrease) in Interest Payable, Net
SILO PHARMA, INC. (SILO) reported Increase (Decrease) in Interest Payable, Net of $52 for the 3-month period ending 2020-03-31, per its 10-Q filed 2020-05-12.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInterestPayableNet · last filed 2020-05-12
- SILO PHARMA, INC. increase (decrease) in interest payable, net for the quarter ending 2020-03-31 was $52.00.
| Period end | Increase (Decrease) in Interest Payable, Net 3 month |
|---|---|
| 2020-03-31 | $52.00 10-Q · filed 2020-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |